Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dual rhinovirus and influenza-targeted nasal spray
- Development stage
- Preclinical
- Lead developer
- Applied Biological Laboratories
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Intranasal
01
Overview
Dual rhinovirus and influenza-targeted nasal spray is a preclinical-stage therapeutic candidate developed by Applied Biological Laboratories. This intranasal formulation is designed to target both rhinovirus and influenza virus, the primary pathogens responsible for the common cold and seasonal flu, respectively. The drug is intended to act locally within the nasal mucosa to block viral binding and entry, potentially utilizing the company's platform of competitive inhibitors and immune-modulating proteins. By preventing the initial stages of viral infection at the primary site of entry, the spray aims to reduce the incidence and severity of respiratory viral infections.
- Other names
- Applied Biological Laboratories dual rhinovirus and influenza nasal sprayApplied Biological Laboratories-rhinovirus-influenza virus-nasal spray-nasal spray-Rhinovirus infection-influenza
02
Targets
Flu (Influenza surface proteins)
Beyond the preview
Go deeper on Dual rhinovirus and influenza-targeted nasal spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dual rhinovirus and influenza-targeted nasal spray.